Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
HS-135 by 35Pharma for Diastolic Heart Failure (HFpEF): Likelihood of Approval
HS-135 is under clinical development by 35Pharma and currently in Phase I for Diastolic Heart Failure (HFpEF). According to GlobalData,...